As we develop important new medicines to treat cancer, Millennium seeks to continuously demonstrate our ethical, clinical and scientific good intentions to the public.

We believe that patients, family members, health professionals and members of the public should have access to medically important information on Millennium clinical research. As such, Millennium is committed to transparency and integrity in its clinical research in keeping with our corporate Core Values. Millennium has been and continues to be committed to complying with all laws and regulations related to the registration and disclosure of our sponsored clinical study information. Millennium is dedicated to the timely registration of clinical studies, communication of clinical study result summaries, and publication of our company-sponsored clinical research.

In addition, Millennium supports the pharmaceutical industry‚Äôs initiatives relating to increased clinical study transparency, including the principles and positions of IFPMA, EFPIA, JPMA, BIO, and PhRMA relative to the disclosure and publication of results from clinical studies for approved medicines. Millennium is committed to complying with the PhRMA/EFPIA and BIO Principles for Responsible Clinical Trial Data Sharing and to providing anonymized individual patient-level data with qualified researchers for legitimate purposes while also safeguarding the privacy of our research participants.

To achieve this goal, Millennium, as the Takeda oncology company, is proud to accept research requests from qualified researchers for patient-level clinical trial data using the Takeda link on the data sharing portal.

Clinical Trial Enrollment and Results

For information about enrolling patients in Millennium-sponsored clinical trials of investigational oncology drugs, please call 1-877-TAKEDA7. For information on Millennium-sponsored clinical trials of marketed oncology drugs, please call 1-866-835-2233, option 1.

Millennium notifies the public of the start of all company-sponsored Phase I, II, III and IV clinical trials designed to test both the safety and efficacy of Millennium investigational and marketed oncology drugs on, a National Institutes of Health registry (a list) of ongoing clinical trials and all other applicable registries according to local laws and regulations.

Millennium publishes results of completed, Phase II, Phase III and Phase IV clinical trials in a timely, objective, accurate and balanced manner — regardless of outcome and also posts summaries of clinical trial results on (and all other applicable registries according to local laws and regulations) and Takeda company websites at and

To Learn More

To learn more about how clinical trials are conducted, search for clinical trials in your area, or learn whether you might qualify to participate in a clinical trial, visit and